No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BLCO240621C15000
- 0.08
- -0.07-46.67%
15min DelayClose Jun 18 15:55 ET
0.15High0.05Low
0.13Open0.15Pre Close95 Volume266 Open Interest15.00Strike Price809.00Turnover40.78%IV2.31%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.08Extrinsic Value100Contract SizeAmericanOptions Type0.2903Delta0.7671Gamma184.25Leverage Ratio-0.0421Theta0.0002Rho53.48Eff Leverage0.0037Vega
Intraday
- 5D
- Daily
News
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
Events Include Symposium on Patient-Centric Approaches to Dry Eye, Highlighting Breakthroughs in Diagnosis, Treatment and Care Bausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to
Wells Fargo Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $23
Wells Fargo analyst Larry Biegelsen maintains $Bausch + Lomb Corp.(BLCO.US)$ with a buy rating, and maintains the target price at $23.According to TipRanks data, the analyst has a success rate of 60.1
Bausch + Lomb INFUSE for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
Bausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of Bausch + Lomb INFUSE for Astigmatism daily
Bausch + Lomb Launches Blink NutriTears Clinically Proven Nutritional Supplement for Dry Eyes in the United States
Bausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Blink NutriTears, a clinically proven over-the-counter
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
Bausch + Lomb Corporation (TSX:BLCO) ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors
Express News | Bausch + Lomb Announced Earlier Health Canada Approved Its EnVista Envy Full Visual Range Intraocular Lens
Comments
In today’s market, one of the biggest winners generating outsized interest is $Emergent BioSolutions(EBS.US$ . This mid-cap biotech company remains a unique turnaround story for investors, and many appear to be placing their bets on this company to come out of the pile as a key winner. Indeed, EBS stock has surged over 70% higher on some intriguing news this afternoon.
The company’s turnaround efforts appear to be receiving a jolt today, wit...
The company’s turnaround efforts appear to be receiving a jolt today, wit...
8
1
1
Upgrades
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgra...
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgra...
7
1
Upgrades
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgr...
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgr...
12
2
Upgrades
• $Zymergen(ZY.US$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $Chewy(CHWY.US$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $Paramount Global-B(PARA.US$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $Roku Inc(ROKU.US$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBS Group(UBS.US$: BofA Securities Downgrades to Neutral from Buy - P...
• $Zymergen(ZY.US$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $Chewy(CHWY.US$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $Paramount Global-B(PARA.US$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $Roku Inc(ROKU.US$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBS Group(UBS.US$: BofA Securities Downgrades to Neutral from Buy - P...
16
1
Read more
Benjamin’s : New CEO